Oxbryta Interactions
There are 373 drugs known to interact with Oxbryta (voxelotor), along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 109 are major, 238 are moderate, and 26 are minor.
- View all 373 medications that may interact with Oxbryta
- View Oxbryta alcohol/food interactions (1)
- View Oxbryta disease interactions (2)
Most frequently checked interactions
View interaction reports for Oxbryta (voxelotor) and the medicines listed below.
- acetaminophen / oxycodone
- Adakveo (crizanlizumab)
- Adriamycin (doxorubicin)
- Advair HFA (fluticasone / salmeterol)
- Advate (antihemophilic factor)
- alendronate
- amlodipine
- Benadryl (diphenhydramine)
- Claritin (loratadine)
- clonazepam
- Dilaudid (hydromorphone)
- Endari (glutamine)
- Exjade (deferasirox)
- Flexeril (cyclobenzaprine)
- folic acid
- gabapentin
- hydroxyurea
- Ingrezza (valbenazine)
- levothyroxine
- losartan
- pantoprazole
- Phenurone (phenacemide)
- prednisone
- Serpazide (hydralazine / hydrochlorothiazide / reserpine)
- sertraline
- Siklos (hydroxyurea)
- trazodone
- Valium (diazepam)
- venlafaxine
- Zofran (ondansetron)
Oxbryta alcohol/food interactions
There is 1 alcohol/food interaction with Oxbryta (voxelotor).
Oxbryta disease interactions
There are 2 disease interactions with Oxbryta (voxelotor) which include:
Report options
QR code containing a link to this page
More about Oxbryta (voxelotor)
- Oxbryta consumer information
- Compare alternatives
- Reviews (7)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
